286 related articles for article (PubMed ID: 15491323)
1. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions.
Hussein MR; Al-Badaiwy ZH; Guirguis MN
J Cutan Pathol; 2004 Nov; 31(10):643-51. PubMed ID: 15491323
[TBL] [Abstract][Full Text] [Related]
2. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
3. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
[TBL] [Abstract][Full Text] [Related]
5. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
6. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
7. Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia.
Furihata M; Sonobe H; Ohtsuki Y; Yamashita M; Morioka M; Yamamoto A; Terao N; Kuwahara M; Fujisaki N
J Pathol; 1996 Feb; 178(2):133-9. PubMed ID: 8683378
[TBL] [Abstract][Full Text] [Related]
8. Expression of apoptosis regulatory proteins p53 and Bcl-2 in skin of patients with chronic renal failure on maintenance haemodialysis.
El-Domyati MM; Ahmad HM; Nagy I; Zahran A
J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):795-801. PubMed ID: 17567310
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53, bcl-2 and growth hormone receptor in actinic keratosis, hypertrophic type.
Stanimirović A; Cupić H; Bosnjak B; Kruslin B; Belicza M
Arch Dermatol Res; 2003 Jul; 295(3):102-8. PubMed ID: 12756585
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
11. Expression of Bcl-2 family proteins in psoriasis.
Batinac T; Zamolo G; Hadzisejdić I; Zauhar G; Brumini G; Ruzić A; Persić V
Croat Med J; 2007 Jun; 48(3):319-26. PubMed ID: 17589974
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
[TBL] [Abstract][Full Text] [Related]
13. Different proliferative patterns characterize different preinvasive breast lesions.
Viacava P; Naccarato AG; Bevilacqua G
J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
[TBL] [Abstract][Full Text] [Related]
14. Relationship of immunohistochemistry scores of altered p53 protein expression in relation to patient's habits and histological grades and stages of squamous cell carcinoma.
Bukhari MH; Niazi S; Chaudhry NA
J Cutan Pathol; 2009 Mar; 36(3):342-9. PubMed ID: 19220630
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
Einspahr JG; Xu MJ; Warneke J; Saboda K; Ranger-Moore J; Bozzo P; Duckett L; Goldman R; Lin P; Buckmeier J; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of Bak expression in oral tongue squamous cell carcinomas.
Xie X; Clausen OP; Boysen M
Oncol Rep; 2003; 10(2):369-74. PubMed ID: 12579274
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.
Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270
[TBL] [Abstract][Full Text] [Related]
18. Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics.
Kalomenidis I; Orphanidou D; Papamichalis G; Vassilakopoulos T; Scorilas A; Rasidakis A; Papastamatiou H; Jordanoglou J; Roussos C
Lung; 2001; 179(5):265-78. PubMed ID: 11976895
[TBL] [Abstract][Full Text] [Related]
19. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.
Dang C; Gottschling M; Roewert J; Forschner T; Stockfleth E; Nindl I
Br J Dermatol; 2006 Oct; 155(4):763-70. PubMed ID: 16965426
[TBL] [Abstract][Full Text] [Related]
20. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
